Literature DB >> 15617629

Patient satisfaction with the SpaceLabs 90207 ambulatory blood pressure monitor in pregnancy.

Susan P Walker1, Michael J Permezel, Shaun P Brennecke, Lynette K Tuttle, John R Higgins.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the acceptability of the SpaceLabs 90207 ambulatory blood pressure monitor among pregnant women.
METHODS: Patients participating in research projects involving ambulatory blood pressure monitoring (ABPM) in pregnancy (N = 110) were asked to complete a questionnaire relating to patient satisfaction on completion of the monitoring period. The first part of the questionnaire involved rating on a visual Likert scale (0-10) whether they found the monitor heavy, noisy, cumbersome, disturbing, or embarrassing to wear. The second part of the questionnaire addressed whether cuff inflation caused significant sleep disturbance or physical discomfort. OUTCOME MEASURES: The mean (SD) and range of the Likert scores are reported. The number of patients reporting sleep disturbance or physical discomfort was calculated. Logistic regression was used to examine which factors were significant predictors of discontinuing monitoring.
RESULTS: The mean (SD) responses measured by the Liken scores were: finding the monitor heavy 3.2 (2.3); comfortable 4.8 (2.3); straightforward to use 8.8 (1.8); cumbersome 3.8 (2.3); disturbing 4.5 (2.7); noisy 1.6 (2.2); and embarrassing to wear 1.7 (2.1). Difficulty initiating sleep was reported by 28.8% of patients, and a further 56.3% reported difficulty maintaining sleep due to the monitor. Sleep disturbance was found to be the strongest predictor [r = 0.52; OR 1.68 (1.23, 2.27), p = 0.0009] for the 15% of patients discontinuing the monitoring.
CONCLUSIONS: While pregnant women tolerate the noise, weight, inconvenience, and disturbance associated with ambulatory blood pressure monitoring (ABPM) well, sleep disturbance is a major cause of dissatisfaction and noncompliance. Future studies should evaluate critically the number of nocturnal blood pressure assessments required, and should allow for a withdrawal rate of approximately 15% when performing sample size calculations for ABPM studies in pregnancy.

Entities:  

Mesh:

Year:  2004        PMID: 15617629     DOI: 10.1081/PRG-200030306

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  6 in total

1.  Maternal prenatal stress phenotypes associate with fetal neurodevelopment and birth outcomes.

Authors:  Kate Walsh; Clare A McCormack; Rachel Webster; Anita Pinto; Seonjoo Lee; Tianshu Feng; H Sloan Krakovsky; Sinclaire M O'Grady; Benjamin Tycko; Frances A Champagne; Elizabeth A Werner; Grace Liu; Catherine Monk
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

2.  Ambulatory Blood Pressure Trajectory and Perceived Stress in Relation to Birth Outcomes in Healthy Pregnant Adolescents.

Authors:  Julie Spicer; Gerald F Giesbrecht; Sally Aboelela; Seonjoo Lee; Grace Liu; Catherine Monk
Journal:  Psychosom Med       Date:  2019-06       Impact factor: 4.312

3.  Acceptance of ambulatory blood pressure monitoring in a semi-rural population in South Africa.

Authors:  Farisai Chiwanza; Yoland Irwin; Ros Dowse
Journal:  Health SA       Date:  2020-06-08

4.  Placental Pathology and Blood Pressure's Level in Women with Hypertensive Disorders in Pregnancy.

Authors:  Vassiliki Krielessi; Nikos Papantoniou; Ioannis Papageorgiou; Ioannis Chatzipapas; Efstathios Manios; Nikos Zakopoulos; Aris Antsaklis
Journal:  Obstet Gynecol Int       Date:  2012-05-07

5.  Tolerability of the Oscar 2 ambulatory blood pressure monitor among research participants: a cross-sectional repeated measures study.

Authors:  Anthony J Viera; Kara Lingley; Alan L Hinderliter
Journal:  BMC Med Res Methodol       Date:  2011-04-27       Impact factor: 4.615

6.  Pre-eclampsia with severe features: management of antihypertensive therapy in the postpartum period.

Authors:  Nnabuike Chibuoke Ngene; Jagidesa Moodley
Journal:  Pan Afr Med J       Date:  2020-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.